BRPI0700969A - composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia - Google Patents

composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia

Info

Publication number
BRPI0700969A
BRPI0700969A BRPI0700969-0A BRPI0700969A BRPI0700969A BR PI0700969 A BRPI0700969 A BR PI0700969A BR PI0700969 A BRPI0700969 A BR PI0700969A BR PI0700969 A BRPI0700969 A BR PI0700969A
Authority
BR
Brazil
Prior art keywords
bacterial
treatment
composition
inflammatory conditions
inflammatory
Prior art date
Application number
BRPI0700969-0A
Other languages
English (en)
Inventor
Neto Dolivar Coraucci
Original Assignee
Ouro Fino Participacoes E Empr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ouro Fino Participacoes E Empr filed Critical Ouro Fino Participacoes E Empr
Priority to BRPI0700969-0A priority Critical patent/BRPI0700969A/pt
Priority to PCT/BR2008/000085 priority patent/WO2008113149A2/en
Priority to US12/532,065 priority patent/US8536143B2/en
Publication of BRPI0700969A publication Critical patent/BRPI0700969A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSIçãO PARA O TRATAMENTO DE AFECçõES BACTERIANAS E INFLAMATóRIAS EM ANIMAIS DE COMPANHIA. A presente invenção refere-se a uma nova composição de macrolídeo, das classes das azalídas denominado Azitromicina, associado um antiínfiamatório não esterálde, o Meloxícam, destinada para animais de companhia, particularmente em cães e gatos, para o tratamento de afecções bactenanas e inflamatónas que acometem cães e gatos Esta invenção visa proporcionar antibioticoterapia de amplo espectro, combatendo a causa das infecções, enquanto trata a inflamação e seus efeitos.
BRPI0700969-0A 2007-03-22 2007-03-22 composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia BRPI0700969A (pt)

Priority Applications (3)

Application Number Priority Date Filing Date Title
BRPI0700969-0A BRPI0700969A (pt) 2007-03-22 2007-03-22 composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia
PCT/BR2008/000085 WO2008113149A2 (en) 2007-03-22 2008-03-24 Observations where certain claims were found unsearchable
US12/532,065 US8536143B2 (en) 2007-03-22 2008-03-24 Compositions to treat bacterial and inflammatory affections in pet animals dosage form and method to treat pet animals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0700969-0A BRPI0700969A (pt) 2007-03-22 2007-03-22 composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia

Publications (1)

Publication Number Publication Date
BRPI0700969A true BRPI0700969A (pt) 2008-11-04

Family

ID=39766524

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0700969-0A BRPI0700969A (pt) 2007-03-22 2007-03-22 composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia

Country Status (3)

Country Link
US (1) US8536143B2 (pt)
BR (1) BRPI0700969A (pt)
WO (1) WO2008113149A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
WO2011107150A1 (en) * 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
CA2792647A1 (en) * 2010-03-10 2011-09-15 Nogra Pharma Limited Compositions for colon lavage and methods of making and using same
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
CN107281155B (zh) * 2017-06-06 2020-04-10 扬子江药业集团四川海蓉药业有限公司 一种阿奇霉素片及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1096862C (zh) * 1994-05-06 2002-12-25 辉瑞大药厂 阿齐霉素的控释剂型
TW200403072A (en) 2002-01-23 2004-03-01 Upjohn Co Combination therapy for the treatment of bacterial infections
US20040214753A1 (en) * 2003-03-20 2004-10-28 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
WO2005044254A1 (en) 2003-10-29 2005-05-19 Idexx Laboratories, Inc. Salts of pharmacologically active compounds
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
US20060058247A1 (en) * 2004-09-16 2006-03-16 Yujiro Hata Methods and compositions for treating cystic fibrosis
WO2006093784A2 (en) 2005-02-25 2006-09-08 Mutual Pharmaceutical Company, Inc. Dosage forms of antibiotics and combinations of antibiotics ans symptomatic relief agents

Also Published As

Publication number Publication date
WO2008113149A2 (en) 2008-09-25
US20100173858A1 (en) 2010-07-08
US8536143B2 (en) 2013-09-17
WO2008113149A3 (en) 2008-11-06

Similar Documents

Publication Publication Date Title
BRPI0700969A (pt) composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia
ECSP088782A (es) Compuestos nuevos
BRPI0518776A2 (pt) composiÇço e mÉtodo para o cuidado oral, e, mÉtodos para inibir a inflamaÇço em um tecido oral de um paciente, e para promover a saéde oral em um paciente
BRPI0519135A2 (pt) macrolÍdeos
BRPI0923855A8 (pt) Ácido lipóico, e, composição de ração de animal de estimação
BRPI0407597A (pt) propriedades anti-angiogênicas e anti-tumorais de inibidores de beta e gama secretase
GT200100036A (es) Derivados de eteres de pirazol como agentes antiinflamatorios / analgesicos.
BRPI0608924A8 (pt) Composição alimentícia, e, método para a criação de um animal.
BR112012016146A2 (pt) uso de piruvatos na preparação de composições para animais de estimação
ECSP056074A (es) Composiciones y método para tratar las infecciones microbianas y parasitarias en el ganado y otros animales
BR112018076404A2 (pt) mitigação de efeito de comprimento de difusão para células lógicas e posicionamento das mesmas
NO20076463L (no) Synergetiske kombinasjoner
BR112022004036A2 (pt) Comprimido mastigável palatável
BR112014011601A2 (pt) bidens pilosa e compostos poliacetilênicos para a prevenção e para o tratamento de coccidiose
BRPI0813159A2 (pt) Composição parasiticida veterinária, método para o tratamento ou controle de uma infecção ou infestação parasiticidas em um animal homeotérico, e, uso de uma composição
BRPI0507486A (pt) métodos para aumentar a flexibilidade da cartilagem em um animal e para fortalecer a cartilagem em um animal, composição para fortalecer cartilagem em um animal, rações para cachorro e para gato, composições para prevenir anormalidades da cartilagem em um animal e para melhorar a flexibiladade da cartilagem em um animal, e, método para impedir a degradação da cartilagem em um animal
BRPI0506279A (pt) composição sinergìstica de antihelmìnticos e endectocidas
BR112012025772A2 (pt) métodos de controle e profilaxia de inflamação e mitigação de condições inflamatórias em animais de estimação
BR112015029260A2 (pt) derivados de tilosina e seu método de preparação
AR055161A1 (es) Combinacion de metionina biodisponible con por lo menos un aceite esencial
Roy et al. Investigation of the aetiology of udder-thigh dermatitis in French dairy cattle
BRPI0514260A (pt) composições alimentìcias para animais de estimação tendo uma propriedade de relaxamento definida
BRPI0806095A2 (pt) associação farmacêutica, composições de uso tópico, formas de dosagens e método para o tratamento de otites agudas ou crÈnicas em animais de companhia
CU20100119A7 (es) Compuestos orgánicos de aminotiazoles
BR112021026797A2 (pt) Composição alimentar para animais

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B11K Dismissal acc. art. 17, par 2 of ipl - pending earlier application (priority claim) definitively shelved

Free format text: PRIORIDADE INTERNA DO PI0801222-9.

B03G Publication of an application: publication cancelled [chapter 3.7 patent gazette]

Free format text: REFERENTE A RPI 1974 DE 04/11/2008.

B03F Publication of an application: publication of application definitely dismissed [chapter 3.6 patent gazette]